SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001563228-18-000006
Filing Date
2018-05-07
Accepted
2018-05-04 20:36:24
Documents
4
Period of Report
2012-04-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K EASTGATE MAY 4, 2018 eastgatebiotech8kapril202018.htm 8-K 13888
2 EASTGATE EXHIBIT 10.1 FORM OF NOTE eastgatepromissorynotesigned.htm EX-10 206667
3 EASTGATE EXHIBIT 10.3 warrantagreementomarahmad18m.htm EX-10 63786
4 EASTGATE EXHIBIT 10.1 warrantagreementomarahmad27m.htm EX-10 64158
  Complete submission text file 0001563228-18-000006.txt   349769
Mailing Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109 8013223401
EASTGATE BIOTECH CORP (Filer) CIK: 0001099574 (see all company filings)

IRS No.: 870639378 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52886 | Film No.: 18809490
SIC: 6799 Investors, NEC